XML 17 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 01, 2022
Oct. 02, 2021
Current assets:    
Cash and cash equivalents $ 274,855 $ 640,101
Accounts receivable, net of allowances of $26,317 and $20,707 as of October 1, 2022, and October 2, 2021 101,206 100,779
Inventories 454,288 185,130
Prepaid and other current assets 37,042 31,504
Total current assets 867,391 957,514
Property and equipment, net 86,168 71,341
Operating lease right-of-use assets 28,329 33,841
Goodwill 77,300 15,545
Intangible assets, net:    
In-process research and development 64,680 20,100
Other intangible assets 26,384 4,350
Deferred tax assets 1,508 10,028
Other noncurrent assets 36,628 26,085
Total assets 1,188,388 1,138,804
Current liabilities:    
Accounts payable 335,758 214,996
Accrued expenses 109,290 108,029
Accrued compensation 23,624 77,695
Deferred revenue, current 27,318 35,866
Other current liabilities 39,649 39,544
Total current liabilities 535,639 476,130
Operating lease liabilities, noncurrent 25,596 33,960
Deferred revenue, noncurrent 56,152 53,632
Deferred tax liabilities 9,642 2,394
Other noncurrent liabilities 846 3,646
Total liabilities 627,875 569,762
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.001 par value; 1,500,000,000 and 500,000,000 shares authorized, 129,823,663 and 128,857,085 shares issued, 126,668,723 and 126,985,273 shares outstanding as of October 1, 2022, and October 2, 2021, respectively 130 129
Treasury stock, 3,154,940 and 1,871,812 shares at cost as of October 1, 2022, and October 2, 2021, respectively (50,896) (50,276)
Additional paid-in capital 617,390 690,462
Accumulated deficit (2,514) (69,897)
Accumulated other comprehensive loss (3,597) (1,376)
Total stockholders' equity 560,513 569,042
Total liabilities and stockholders’ equity $ 1,188,388 $ 1,138,804